315 related articles for article (PubMed ID: 24319191)
1. Current management of immune thrombocytopenia.
Neunert CE
Hematology Am Soc Hematol Educ Program; 2013; 2013():276-82. PubMed ID: 24319191
[TBL] [Abstract][Full Text] [Related]
2. Immune thrombocytopenia (ITP): Pathophysiology update and diagnostic dilemmas.
LeVine DN; Brooks MB
Vet Clin Pathol; 2019 Oct; 48 Suppl 1():17-28. PubMed ID: 31538353
[TBL] [Abstract][Full Text] [Related]
3. Antibody binding to megakaryocytes in vivo in patients with immune thrombocytopenia.
Arnold DM; Nazi I; Toltl LJ; Ross C; Ivetic N; Smith JW; Liu Y; Kelton JG
Eur J Haematol; 2015 Dec; 95(6):532-7. PubMed ID: 25684257
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of hypoxia-inducible factor-1α contributes to impaired megakaryopoiesis in immune thrombocytopenia.
Qi J; You T; Pan T; Wang Q; Zhu L; Han Y
Thromb Haemost; 2017 Oct; 117(10):1875-1886. PubMed ID: 28771276
[TBL] [Abstract][Full Text] [Related]
5. Thrombosis in patients with primary chronic immune thrombocytopenia.
Nørgaard M
Thromb Res; 2012 Oct; 130 Suppl 1():S74-5. PubMed ID: 23026671
[TBL] [Abstract][Full Text] [Related]
6. Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro.
Iraqi M; Perdomo J; Yan F; Choi PY; Chong BH
Haematologica; 2015 May; 100(5):623-32. PubMed ID: 25682608
[TBL] [Abstract][Full Text] [Related]
7. Novel scientific approaches and future research directions in understanding ITP.
Hicks SM; Coupland LA; Jahangiri A; Choi PY; Gardiner EE
Platelets; 2020; 31(3):315-321. PubMed ID: 32054377
[TBL] [Abstract][Full Text] [Related]
8. Immune Thrombocytopenia Plasma-Derived Exosomes Impaired Megakaryocyte and Platelet Production through an Apoptosis Pathway.
Miao W; Song B; Shi B; Wan Q; Lv Q; Chen H; Zhu M; Zhang L; Han Y; Wu D
Thromb Haemost; 2021 Apr; 121(4):495-505. PubMed ID: 33124021
[TBL] [Abstract][Full Text] [Related]
9. Platelet destruction in immune thrombocytopenia. Understanding the mechanisms.
Bakchoul T; Sachs UJ
Hamostaseologie; 2016 Aug; 36(3):187-94. PubMed ID: 25982994
[TBL] [Abstract][Full Text] [Related]
10. Low-dose decitabine promotes megakaryocyte maturation and platelet production in healthy controls and immune thrombocytopenia.
Zhou H; Hou Y; Liu X; Qiu J; Feng Q; Wang Y; Zhang X; Min Y; Shao L; Liu X; Li G; Li L; Yang L; Xu S; Ni H; Peng J; Hou M
Thromb Haemost; 2015 May; 113(5):1021-34. PubMed ID: 25566808
[TBL] [Abstract][Full Text] [Related]
11. New Developments in the Pathophysiology and Management of Primary Immune Thrombocytopenia.
Althaus K; Faul C; Bakchoul T
Hamostaseologie; 2021 Aug; 41(4):275-282. PubMed ID: 33348391
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis and management of chronic idiopathic thrombocytopenic purpura: an update.
Yang R; Han ZC
Int J Hematol; 2000 Jan; 71(1):18-24. PubMed ID: 10729989
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet antibody-induced thrombocytopenia does not correlate with megakaryocyte abnormalities in murine immune thrombocytopenia.
Guo L; Kapur R; Aslam R; Hunt K; Hou Y; Zufferey A; Speck ER; Rondina MT; Lazarus AH; Ni H; Semple JW
Scand J Immunol; 2018 Jul; 88(1):e12678. PubMed ID: 29855061
[TBL] [Abstract][Full Text] [Related]
14. Intrinsically impaired platelet production in some patients with persistent or chronic immune thrombocytopenia.
Rivière É; Viallard JF; Guy A; Kilani B; Vieira-Dias J; Pons AC; Couffinhal T; Pellegrin JL; James C
Br J Haematol; 2015 Aug; 170(3):408-15. PubMed ID: 25873418
[TBL] [Abstract][Full Text] [Related]
15. [Idiopathic thrombocytopenic purpura in children].
Gebauer E; Vijatov G
Med Pregl; 1998; 51(3-4):127-34. PubMed ID: 9611955
[TBL] [Abstract][Full Text] [Related]
16. Current therapies in primary immune thrombocytopenia.
Pels SG
Semin Thromb Hemost; 2011 Sep; 37(6):621-30. PubMed ID: 22102265
[TBL] [Abstract][Full Text] [Related]
17. The spleen dictates platelet destruction, anti-platelet antibody production, and lymphocyte distribution patterns in a murine model of immune thrombocytopenia.
Aslam R; Kapur R; Segel GB; Guo L; Zufferey A; Ni H; Semple JW
Exp Hematol; 2016 Oct; 44(10):924-930.e1. PubMed ID: 27417974
[TBL] [Abstract][Full Text] [Related]
18. Sequence of treatments for adults with primary immune thrombocytopenia.
George JN
Am J Hematol; 2012 May; 87 Suppl 1():S12-5. PubMed ID: 22389032
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet antibodies detected by the MAIPA assay in newly diagnosed immune thrombocytopenia are associated with chronic outcome and higher risk of bleeding.
Grimaldi D; Canouï-Poitrine F; Croisille L; Lee K; Roudot-Thoraval F; Languille L; Khellaf M; Michel M; Godeau B; Bierling P
Ann Hematol; 2014 Feb; 93(2):309-15. PubMed ID: 23912633
[TBL] [Abstract][Full Text] [Related]
20. The pathophysiology of ITP revisited: ineffective thrombopoiesis and the emerging role of thrombopoietin receptor agonists in the management of chronic immune thrombocytopenic purpura.
Gernsheimer TB
Hematology Am Soc Hematol Educ Program; 2008; ():219-26. PubMed ID: 19074086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
